Virtual reality in medicine: Beyond bulky goggles

Mayo Clinic electrophysiologist Suraj Kapa, M.D.,discusses virtual reality and how this technology is being applied to medicine in this video first shown on Medscape Cardiology.

Cardiac sarcoidosis

Leslie T. Cooper, M.D., a cardiologist at Mayo Clinic discusses treatment options for patients with cardiac sarcoidosis.

Myocarditis: The great mimicker

Leslie T. Cooper, M.D., a cardiologist at Mayo Clinic discusses prevalence of myocarditis and when to consider a myocarditis diagnosis.

TTR vs. AL cardiac amyloidosis: Don't rely on imaging alone

Mayo Clinic cardiologists Martha Grogan, M.D., and Omar F. Abou Ezzeddine, M.D., C.M., M.S., discuss transthyretin (TTR) amyloidosis and AL amyloidosis.

CABANA post-publication takeaways for catheter ablation of atrial fibrillation

Mayo Clinic electrophysiologists Douglas L. Packer, M.D., Thomas M. Munger, M.D., and Peter A. Noseworthy, M.D., discuss the outcomes, strengths and limitations of the Catheter Ablation versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation ...

Good news/bad news: Mayo Clinic commentary on what to expect from the ISCHEMIA trial

Mayo Clinic cardiologist Raymond J. Gibbons, M.D., discusses the success and cautionary indicators of the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial.

Robotic approach to mitral valve repair: Mayo Clinic experience

Richard C. Daly, M.D., a cardiovascular surgeon at Mayo Clinic, discusses the robotic approach to repair of mitral valve regurgitation related to leaflet prolapse (degenerative mitral valve disease).

Recognizing left bundle branch block and when it matters

Mayo Clinic electrophysiologists Siva K. Mulpuru, M.D., and Suraj Kapa, M.D., discuss left bundle branch block — an abnormal conduction in the heart frequently seen on electrocardiogram — with Yogesh N. Reddy, M.B.B.S. Treatment for the ...

Closing the gap between clinical trials and practice: NOACs for atrial fibrillation

Cardiac electrophysiologist Peter A. Noseworthy, M.D., discusses the use of observational data to close the gap between clinical trials and clinical practice, specifically nonvitamin K oral anticoagulants (NOACs).